Asian Spectator


The Times

.

Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner

  • Written by PR Newswire Asia - Asian Spectator

SYDNEY, Oct. 27, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") today announced its intention to request and hold a follow-up Type C meeting with the U.S. Food & Drug Administration (FDA) to discuss overall survival (OS) findings in newly diagnosed glioblastoma (GBM) patients treated with paxalisib and to seek...

Magazine

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

Why Early Protection of Intellectual Assets is Critical

For many businesses, intellectual assets are among the most valuable things they own, yet they're often the last to receive formal legal protection. A brand name or a proprietary process can represe...

Konservasi gaya lama tak efektif: Pemulihan Aceh perlu warga dengan ekonomi yang merawat hutan

shutterstock(Manthofana/Shutterstock)● Peminggiran warga dari konservasi hutan Lingga Isaq menjadi salah satu faktor yang memperparah dampak bencana.● Pertanian monokultur dan tambang emas...

hacklink hack forum hacklink film izle hacklink z-libraryGrandpashabetjojobetcasibomgrandpashabetDeneme bonusu veren siteler 2026Deneme bonusu veren siteler 2026Grandpashabetjojobet giriş爱思助手下载jojobetjojobetjojobetmarsbahisjojobetmarsbahisjojobetjojobetmarsbahistelegram下载jojobetDeneme Bonusu Veren Sitelercasino sitelericratosroyalbet有道翻译下载betasus girişmarsbahisgrandpashabetgrandpashabetjojobetjojobetgrandpashabetjojobetjojobetjojobet